Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 9, 2009, Pages 3282-3288

  Maliqueo, Manuel ^a   Sir Petermann, Teresa ^a   Pérez, Virginia ^a   Echiburú, Bárbara ^a   De Guevara, Amanda Ladrón ^a   Gálvez, Carla ^a   Crisosto, Nicolás ^a   Azziz, Ricardo ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; CYTOCHROME P450C17; GLUCOSE; HYDROXYPROGESTERONE; INSULIN; PRASTERONE; PRASTERONE SULFATE; TETRACOSACTIDE;

ADOLESCENT; ADRENAL FUNCTION; ADRENARCHE; ADULT; ARTICLE; BODY MASS; BONE AGE; CHILD; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROVOCATION TEST; PUBERTY; SCHOOL CHILD;

EID: 69949102339     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0427     Document Type: Article

References (51)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749 (Pubitemid 38766360)
2. Zawadzky JK, Dunaif A 1992 Diagnosis criteria: towards a rational approach. In: Hershmann JM, ed. Current issues in endocrinology and metabolism. Boston: Blackwell Scientific Publications; 377-384
3. Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
4. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R 1998 Prevalence of the polycystic ovary syndrome in unselected black and whitewomenof the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078-3082 (Pubitemid 28500937)
5. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA 1992 Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 167:1807-1812
6. Wild RA, Umstot ES, Andersen RN, Ranney GB, Givens JR 1983 Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. Am J Obstet Gynecol 146:602-606
7. Hoffman DI, Klove K, Lobo RA 1984 The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil Steril 42:76-81 (Pubitemid 14086154)
8. Holte J 1996 Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Baillieres Clin Endocrinol Metab 10:221-247 (Pubitemid 26166053)
9. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174 (Pubitemid 19250404)
10. Nader S 2007 Adrenarche and polycystic ovary syndrome: a tale of two hypotheses. J Pediatr Adolesc Gynecol 20:353-360 (Pubitemid 350235976)
11. Pasquali R, Patton L, Pocognoli P, Cognigni GE, Gambineri A 2007 17-Hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. J Clin Endocrinol Metab 92:4208-4217 (Pubitemid 350074733)
12. Ibáñez L, Dimartino-Nardi J, Potau N, Saenger P 2000 Premature adrenarche-normal variant or forerunner of adult disease? Endocr Rev 21:671-696
13. Auchus RJ, Rainey WE 2004 Adrenarche-physiology, biochemistry and human disease. Clin Endocrinol (Oxf) 60:288-296
14. Miller WL 1999 The molecular basis of premature adrenarche: an hypothesis. Acta Paediatr Suppl 88:60-66
15. Veldhuis JD, Roemmich JN, Richmond EJ, Bowers CY 2006 Somatotropic and gonadotropic axes linkages in infancy, childhood and the puberty-adult transition. Endocr Rev 27:101-140
16. Sizonenko PC, Paunier L 1975 Hormonal changes in puberty III: correlation of plasma dehydroepiandrosterone, testosterone, FSH, andLHwith stages of puberty and bone age in normal boys and girls and in patients with Addison's disease or hypogonadism or with premature or late adrenarche. J Clin Endocrinol Metab 41:894-904
17. Yen SSCJ, Chaney C, Judd HL 1976 Functional aberrations of the hypothalamic-pituitary system in polycystic ovary syndrome: a consideration of the pathogenesis. In: Serio M, ed. The endocrine function of the human ovary. New York: Academic Press; 373-383
18. Ibañez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinyé M, Carrascosa A, Vicens-Calvet E 1993 Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76:1599-1603 (Pubitemid 23164385)
19. Siklar Z, Oçal G, Adiyaman P, Ergur A, Berberoolu M 2007 Functional ovarian hyperandrogenism and polycystic ovary syndrome in prepubertal girls with obesity and/or premature pubarche. J Pediatr Endocrinol Metab 20:475-481 (Pubitemid 46865027)
20. Oppenheimer E, Linder B, DiMartino-Nardi J 1995 Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans. J Clin Endocrinol Metab 80:614-618
21. Ibáñez L, Potau N, Zampolli M, Riqué S, Saenger P, Carrascosa A 1997 Hyperinsulinemia and decreased insulin-like growth factor binding protein-1 are common features in prepubertal and postpubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 82:2283-2288 (Pubitemid 27287601)
22. Utriainen P, Jääskeläinen J, Romppanen J, Voutilainen R 2007 Childhood metabolic syndrome and its components in premature adrenarche. J Clin Endocrinol Metab 92:4282-4285 (Pubitemid 350074744)
23. Ibañez L, Virdis R, Potau N, Zampolli M, Ghizzoni L, Albisu MA, Carrascosa A, Bernasconi S, Vicens-Calvet E 1992 Natural history of premature pubarche: an auxological study. J Clin Endocrinol Metab 74:254-257
24. Pere A, Perheentupa J, Peter M, Voutilainen R 1995 Follow-up of growth and steroids in premature adrenarche. Eur J Pediatr 154: 346-352
25. Sopher AB, Thornton JC, Silfen ME, Manibo A, Oberfield SE, Wang J, Pierson Jr RN, Levine LS, Horlick M 2001 Prepubertal girls with premature adrenarche have greater bone mineral content and density than controls. J Clin Endocrinol Metab 86:5269-5272 (Pubitemid 33070247)
26. Ibáñez L, Potau N, Francois I, de Zegher F 1998 Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 83:3558-3662 (Pubitemid 28500889)
27. Neville KA, Walker JL 2005 Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity. Arch Dis Child 90: 258-261
28. Ibáñez L, Potau N, Marcos MV, de Zegher F 1999 Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab 84:4739-4741 (Pubitemid 30677704)
29. Sir-Petermann T, Hitchsfeld C, Maliqueo M, Codner E, Echiburú B, Gazitúa R, Recabarren S, Cassorla F 2005 Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod 20: 2122-2126 (Pubitemid 41418494)
30. Sir-Petermann T, Codner E, Maliqueo M, Echiburú B, Hitschfeld C, Crisosto N, Pérez-Bravo F, Recabarren SE, Cassorla F 2006 Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:3105-3109 (Pubitemid 44271764)
31. Crisosto N, Codner E, Maliqueo M, Echiburú B, Sánchez F, Cassorla F, Sir-Petermann T 2007 Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 92:2739-2743 (Pubitemid 47037384)
32. Sir-Petermann T, Maliqueo M, Codner E, Echiburú B, Crisosto N, Pérez V, Pérez-Bravo F, Cassorla F 2007 Early metabolic derangements in daughters ofwomenwith polycystic ovary syndrome. J Clin Endocrinol Metab 92:4637-4642 (Pubitemid 350223438)
33. Sir-Petermann T, Codner E, Pérez V, Echiburú B, Maliqueo M, Ladrón de Guevara A, Preisler J, Crisosto N, Sánchez F, Cassorla F, Bhasin S 2009 Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 94:1923-1930
34. Juez G, Lucero E, Ventura-Juncá P, González H, Tapia JL, Winter A 1989 Intrauterine growth in Chilean middle class newborn infants. Rev Chil Pediatr 60:198-202
35. Hatch R, Rosenfield RL, Kim MH, Tredway D 1981 Hirsutism: implications, etiology, and management.AmJ Obstet Gynecol 140: 815-830
36. Maliqueo M, Atwater I, Lahsen R, Pérez-Bravo F, Angel B, Sir- Petermann T 2003 Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of β-cell dysfunction? Hum Reprod 18:2683-2688
37. Adams J, Polson DW, Franks S 1986 Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 293:355-359 (Pubitemid 16034121)
38. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR 2004 Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89:453-462 (Pubitemid 38269843)
39. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL 2002 Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45-60 (Pubitemid 34049426)
40. Greulich WW, Pyle SI 1966 Radiographic atlas of skeletal development of the hand and wrist. Stanford, CA: Stanford University Press
41. Rosenfield RL 2007 Clinical review: identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 92:787-796 (Pubitemid 46465641)
42. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
43. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470 (Pubitemid 29418240)
44. Zhang LH, Rodriguez H, Ohno S, Miller WL 1995 Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci USA 92:10619-10623
45. Arlt W, Martens JW, Song M, Wang JT, Auchus RJ, Miller WL 2002 Molecular evolution of adrenarche: structural and functional analysis of p450c17 from four primate species. Endocrinology 143:4665-4672 (Pubitemid 35397608)
46. Carmina E 2006 Ovarian and adrenal hyperandrogenism. Ann NY Acad Sci 1092:130-137
47. Rosenfield RL 1999 Ovarian and adrenal function in polycystic ovary syndrome. Endocrinol Metab Clin North Am 28:265-293 (Pubitemid 29242714)
48. Remer T, Manz F 1999 Role of nutritional status in the regulation of adrenarche. J Clin Endocrinol Metab 84:3936-3944 (Pubitemid 30644177)
49. Kahsar-Miller M, Boots LR, Bartolucci A, Azziz R 2004 Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. Fertil Steril 82:973-975 (Pubitemid 39346456)
50. Goodarzi MO, Antoine HJ, Azziz R 2007 Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome. J Clin Endocrinol Metab 92:2659-2664 (Pubitemid 47037373)
51. Goodarzi MO, Xu N, Azziz R 2008 Association of CYP3A7* 1Cand serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab 93:2909-2912 (Pubitemid 352008570)